Om Megashree Pharmaceuticals IPO Approved by SEBON: 1.8 Million Shares to be Issued

Om Megashree Pharmaceuticals IPO
Share It On:

17th January 2025, Kathmandu

Om Megashree Pharmaceuticals Limited has officially received approval from the Securities Board of Nepal (SEBON) to issue an Initial Public Offering (IPO) of 1.8 million shares, valued at NPR 18 million.

Om Megashree Pharmaceuticals IPO Approved

The approval, granted on January 16, sets the stage for the company’s entry into the Nepalese capital market.

Details of the IPO

The company will issue shares worth NPR 180 million, a move that will increase its paid-up capital to NPR 600 million. The IPO marks a significant milestone for Om Megashree as it prepares to raise funds for expansion.

First Pharmaceutical Company in Nepal to Go Public

This IPO is a groundbreaking development, as Om Megashree Pharmaceuticals became the first pharmaceutical company in Nepal to enter the capital market. The move signifies a new era for the pharmaceutical sector, with opportunities for public investment in the industry.

Prabhu Capital to Manage the IPO

Om Megashree has appointed Prabhu Capital as the issue manager for the IPO. The company will oversee the distribution of shares to the public, ensuring a smooth and efficient process for investors.

Aiming for Growth and Expansion

The IPO aims to raise capital for further business expansion, allowing Om Megashree to enhance its products and services. This move will benefit both the company and Nepal’s pharmaceutical sector by improving product accessibility and public health outcomes.

Impact on Nepal’s Pharmaceutical Sector

The issuance of the IPO will create new opportunities for investors and provide necessary funding for Om Megashree’s growth. The pharmaceutical sector in Nepal is expected to benefit from increased public investment and improved industry transparency.

With the SEBON approval in place, Om Megashree Pharmaceuticals is ready to make history as the first pharmaceutical company in Nepal to go public. This significant step will open doors for the company and transform the landscape of the Nepalese pharmaceutical market.

For more: Om Megashree Pharmaceuticals IPO Approved


Share It On:

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Posts

Nepal Bank Housing Loan Scheme: Saral Awas Karja for Easy Homeownership with 6.63% Interest

Nepal Bank Housing Loan Scheme: Saral Awas Karja for Easy

Share It On:29th January 2025, Kathmandu Nepal Bank Limited, the first bank of Nepal, has launched a new housing loan

IME Life Insurance Q2 Earnings Report: 14% Profit Growth, Life Insurance Fund, Premium Collection

IME Life Insurance Q2 Earnings Report: 14% Profit Growth, Life

Share It On:29th January 2025, Kathmandu IME Life Insurance has made history as the first insurance company to release its

Global IME Laghubitta Q1 Earnings: 147% Growth, Improved NPLs, Increased Deposits – Microfinance Sector

Global IME Laghubitta Q1 Earnings: 147% Growth, Improved NPLs, Increased

Share It On:29th January 2025, Kathmandu Global IME Laghubitta has reported a significant profit increase of 147.57% in the first

NECO Insurance Hiring Nationwide: Multiple Job Openings for Branch Managers, Officers, and More

NECO Insurance Hiring Nationwide: Multiple Job Openings for Branch Managers,

Share It On:29th January 2025, Kathmandu NECO Insurance Ltd. is hiring for a wide range of positions across Nepal. The

Nepal Startup & SME Conference 2025: Deuba Advocates Innovation, Investment for Economic Growth

Nepal Startup & SME Conference 2025: Deuba Advocates Innovation, Investment

Share It On:29th January 2025, Kathmandu Sher Bahadur Deuba, President of the Nepali Congress, opened the Nepal Startup and SME

Nepal Health Ministry Cracks Down on Illegal Unregistered Vitamin & Mineral Supplement Sales

Nepal Health Ministry Cracks Down on Illegal Unregistered Vitamin &

Share It On: 29th January 2025, Kathmandu The Ministry of Health and Population has issued a strong warning against the